Cargando…
Comparative Cytochrome P450 In Vitro Inhibition by Atypical Antipsychotic Drugs
The goal of this study was to assess in human liver microsomes the inhibitory capacity of commonly used antipsychotics on the most prominent CYP450 drug metabolizing enzymes (CYP1A2, CYP2C9, CYP2D6, and CYP3A). Chlorpromazine was the only antipsychotic that inhibited CYP1A2 activity (IC(50) = 9.5 μM...
Autores principales: | Gervasini, Guillermo, Caballero, Maria J., Carrillo, Juan A., Benitez, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586484/ https://www.ncbi.nlm.nih.gov/pubmed/23476805 http://dx.doi.org/10.1155/2013/792456 |
Ejemplares similares
-
In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug–drug interactions
por: Wójcikowski, Jacek, et al.
Publicado: (2020) -
Antipsychotic-induced priapism in an HIV patient: a cytochrome P450-mediated drug interaction
por: Geraci, Matthew J., et al.
Publicado: (2010) -
Cytochrome P450 (CYP450) Interactions Involving Atypical Antipsychotics Are Common in Community-Dwelling Older Adults Treated for Behavioral and Psychological Symptoms of Dementia
por: Matos, Adriana, et al.
Publicado: (2020) -
The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions
por: Danek, Przemysław J., et al.
Publicado: (2020) -
Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo
por: Wang, Yiran, et al.
Publicado: (2020)